
Cell & Gene Therapy Manufacturing Services Market Size, Share, By Type, Workflow, Mode, Indication, Application, and Region - Trends, Analysis, and Forecast till 2035
Description
Cell & Gene Therapy Manufacturing Services Market Size, Share, By Type, Workflow, Mode, Indication, Application, and Region - Trends, Analysis, and Forecast till 2035
Cell & gene therapy manufacturing services encompasses a range of specialized processes and technologies aimed at producing cell-based and gene-based therapies. These services are critical in the biopharmaceutical industry, which focuses on the development and manufacturing of innovative treatments designed to modify genetic material to treat, prevent, and potentially cure diseases. The market is expected to grow due to the surging reliance on contract development and manufacturing organizations (CDMOs) globally.
Report Highlights:
- By 2035, the cell & gene therapy manufacturing services market size is expected to achieve a valuation of USD 42.3 billion.
- In 2024, the market was worth USD 8.4 billion.
- The focused market is expected to witness a steady CAGR of 19.4%.
- North America held the largest share of the market in 2024.
- Asia Pacific is expected to be the fastest-growing region in the market.
- By type, the market is being dominated by the cell therapy segment.
- On the basis of workflow, the cell processing segment is leading the market.
- Based on mode, the market is dominated by the contract manufacturing segment.
- Under indication, the oncology segment holds the largest cell & gene therapy services market share.
- In October 2024, Governor Kathy Hochul unveiled plans for New York BioGenesis Park, a groundbreaking USD 430 million Cell and Gene Therapy Innovation Hub in Nassau County, Long Island. To be developed by The Albanese Organization, Inc., and this state-of-the-art facility would catalyze CGT research, development, clinical manufacturing, and commercialization across New York state.
- In September 2024, LumaCyte, a leader in advanced cellular analysis and precision bioanalytics, proudly announced the launch of its groundbreaking cell therapy application for predictive CAR T donor analytics. Leveraging its novel Laser Force Cytology technology and Radiance instrument, LumaCyte uncovers deep data insights into highly variable and complex patient and donor cellular starting material, enabling cell therapy developers to predict manufacturing success for specific donors or patients.
Acquisition & Partnership:
- For instance, in January 2024, Kyowa Kirin Co., Ltd. a Japan-based global specialty pharmaceutical company (J-GSP) discovering and developing novel medicines utilizing the latest biotechnology, and Orchard Therapeutics plc, a global gene therapy leader, today announced Kyowa Kirin has successfully completed the acquisition of Orchard Therapeutics.
- For instance, in July 2024, Genezen, a best-in-class gene therapy CDMO, announced an agreement to acquire uniQure's commercial gene therapy operations in Lexington, MA, bringing a strategic manufacturing facility and a world-class team of employees to the company.
Browse ∼50 market data tables and ∼45 figures through ∼173 slides and in-depth TOC on “Cell & Gene Therapy Manufacturing Services Market Size, Share, By Type, Workflow, Mode, Indication, Application, and Region - Trends, Analysis, and Forecast till 2035”
Cell & Gene Therapy Manufacturing Services Market Competitive Landscape:
The major players operating in the market are Lonza Group, KBI Biopharma, Inc., Cell Therapies Pty Ltd., RoslinCT, CGT Catapult, ABL, Inc., Batavia Biosciences B.V., Aldevron LLC., Oxford Biomedica USA, Vivebiotech, Rentschler Biopharma, AGC Biologics, ElevateBio, Pharmaron, Recipharm AB, and Exothera.
Table of Contents
173 Pages
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Workflow
- Market Snippet, By Mode
- Market Snippet, By Indication
- Market Snippet, By End-User
- Market Snippet, By Region
- Opportunity Map Analysis
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Type Launch
- Merger and Acquisitions
- Impact Analysis
- PEST Analysis
- Porter’s Analysis
- Acquisition & Partnership Scenario
- Pipeline Analysis
- cGMP cell therapy development and manufacturing services
- Regulatory Framework
- The future of cell and gene therapy manufacturing
- Market Segmentation, By Type, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Cell Therapy
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Allogeneic
- Autologous
- Gene Therapy
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Viral Vectors
- Non-Viral Vectors
- Market Segmentation, By Workflow, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Cell Processing
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Cell Banking
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Process Development
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Fill & Finish Operations
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Analytical and Quality Testing
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Raw Material Testing
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Mode, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- In-House Manufacturing
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Contract Manufacturing
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Indication, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Oncology Diseases
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Cardiovascular Diseases
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Orthopedic Diseases
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Infectious Diseases
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Ophthalmology Diseases
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Other Indications
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By End-User, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Hospitals & Clinics
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Biopharmaceutical Companies
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Academic Research Institutes
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Other End Users
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- North America
- Market Size and Forecast (USD Bn), By Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Workflow, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Mode, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Indication, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- U.S.
- Canada
- Asia Pacific
- Market Size and Forecast (USD Bn), By Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Workflow, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Mode, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Indication, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
- Europe
- Market Size and Forecast (USD Bn), By Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Workflow, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Mode, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Indication, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
- Latin America
- Market Size and Forecast (USD Bn), By Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Workflow, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Mode, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Indication, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East and Africa
- Market Size and Forecast (USD Bn), By Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Workflow, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Mode, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Indication, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- GCC
- Israel
- South Africa
- Rest of Middle East and Africa
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Lonza Group
- KBI Biopharma, Inc.
- Cell Therapies Pty Ltd.
- RoslinCT
- CGT Catapult
- ABL, Inc.
- Batavia Biosciences B.V.
- Aldevron LLC.
- Oxford Biomedica USA
- Vivebiotech
- Rentschler Biopharma
- AGC Biologics
- ElevateBio
- Pharmaron
- Recipharm AB
- Exothera
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.